Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 5056 AL 5070

Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial

Dysken MW, Sano M, Asthana S, Vertrees JE, Pallaki M, Llorente M, Love S, Schellenberg GD, McCarten JR, Malphurs J, Prieto S, Chen P, Loreck DJ, Trapp G, Bakshi RS, Mintzer JE, Heidebrink JL, Vidal-Cardona A, Arroyo LM, Cruz AR, Zachariah S, Kowall NW, Chopra MP, Craft S, Thielke S, Turvey CL, Woodman C, Monnell KA, Gordon K, Tomaska J, Segal Y, Peduzzi PN, Guarino PD.

JAMA. 2014 Jan 1;311(1):33-44. doi: 10.1001/jama.2013.282834.

Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease

Iqbal K, Gong CX, Liu F.

Expert Opin Ther Targets. 2014 Mar;18(3):307-18. doi: 10.1517/14728222.2014.870156. Epub 2014 Jan 3.

Emerging therapeutics for Alzheimer's disease

Chiang K, Koo EH.

Annu Rev Pharmacol Toxicol. 2014;54:381-405. doi: 10.1146/annurev-pharmtox-011613-135932.

Omega-3 fatty acids: a growing ocean of choices

Fares H, Lavie CJ, DiNicolantonio JJ, O'Keefe JH, Milani RV.

Curr Atheroscler Rep. 2014 Feb;16(2):389. doi: 10.1007/s11883-013-0389-6.

Intranasal therapeutic strategies for management of Alzheimer's disease

Sood S, Jain K, Gowthamarajan K.

J Drug Target. 2014 May;22(4):279-94. doi: 10.3109/1061186X.2013.876644. Epub 2014 Jan 9.

The treatment of Alzheimer's disease using Chinese medicinal plants: from disease models to potential clinical applications

Su Y, Wang Q, Wang C, Chan K, Sun Y, Kuang H.

J Ethnopharmacol. 2014 Mar 28;152(3):403-23. doi: 10.1016/j.jep.2013.12.053. Epub 2014 Jan 9.

Role of Medium Chain Triglycerides (Axona®) in the Treatment of Mild to Moderate Alzheimer's Disease

Sharma A, Bemis M, Desilets AR.

Am J Alzheimers Dis Other Demen. 2014 Aug;29(5):409-14. doi: 10.1177/1533317513518650. Epub 2014 Jan 9.

Efficacy and safety evaluation of HSD-1 inhibitor ABT-384 in Alzheimer's disease

Marek GJ, Katz DA, Meier A, Greco N 4th, Zhang W, Liu W, Lenz RA.

Alzheimers Dement. 2014 Oct;10(5 Suppl):S364-73. doi: 10.1016/j.jalz.2013.09.010. Epub 2014 Jan 10.

γ-Secretase modulators: current status and future directions

Hall A, Patel TR.

Prog Med Chem. 2014;53:101-45. doi: 10.1016/B978-0-444-63380-4.00003-2.

[Cellular models for individualized medicine in Alzheimer's disease using patient-derived induced pluripotent stem cells]

Asai M, Shirotani K, Kondo T, Inoue H, Iwata N.

Nihon Yakurigaku Zasshi. 2014 Jan;143(1):23-6. doi: 10.1254/fpj.143.23.

Effect of TTP488 in patients with mild to moderate Alzheimer's disease

Burstein AH, Grimes I, Galasko DR, Aisen PS, Sabbagh M, Mjalli AM.

BMC Neurol. 2014 Jan 15;14:12. doi: 10.1186/1471-2377-14-12.

Therapeutic implications of the prostaglandin pathway in Alzheimer's disease

Cudaback E, Jorstad NL, Yang Y, Montine TJ, Keene CD.

Biochem Pharmacol. 2014 Apr 15;88(4):565-72. doi: 10.1016/j.bcp.2013.12.014. Epub 2014 Jan 13.

The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area

Araki T, Wake R, Miyaoka T, Kawakami K, Nagahama M, Furuya M, Limoa E, Liaury K, Hashioka S, Murotani K, Horiguchi J.

Int J Geriatr Psychiatry. 2014 Sep;29(9):881-9. doi: 10.1002/gps.4074. Epub 2014 Jan 17.

Antiamyloid therapy for Alzheimer's disease--are we on the right road?

Karran E, Hardy J.

N Engl J Med. 2014 Jan 23;370(4):377-8. doi: 10.1056/NEJMe1313943.

A brief report on the efficacy of donepezil in pain management in Alzheimer's disease

Gharaei H, Shadlou H.

J Pain Palliat Care Pharmacother. 2014 Mar;28(1):37-9. doi: 10.3109/15360288.2013.876484. Epub 2014 Jan 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias